Company Filing History:
1 out of 569 
1 out of 20 
1 out of 34 Years Active: 2014
Title: Gabriella Gobbi: A Pioneer in Melatonin Research
Introduction
Gabriella Gobbi, an innovative researcher based in Montreal, Canada, is recognized for her significant contributions to the field of pharmacology. With a focus on melatonin ligands, she has dedicated her research to exploring compounds with antidepressant activity and sleep-inducing properties.
Latest Patents
Gobbi holds a patent titled "Melatonin ligands having antidepressant activity as well as sleep inducing properties." This patent encompasses novel melatonin ligands described by a complex chemical formula, offering potential for advancement in treatments for mood disorders and sleep issues.
Career Highlights
Throughout her career, Gabriella has had the privilege of working with prominent institutions, including McGill University and Università degli Studi di Parma. Her research has not only advanced the understanding of melatonin but also contributed to the development of pharmaceuticals aimed at improving mental health and sleep quality.
Collaborations
Gabriella has collaborated with esteemed colleagues, including Marco Mor and Silvia Rivara. These partnerships have led to groundbreaking research endeavors, enhancing the impact of her work in the scientific community.
Conclusion
As a pioneering inventor, Gabriella Gobbi's work in the field of melatonin research continues to inspire and foster innovation. Her patent and collaborative efforts pave the way for future advancements in understanding and treating mental health and sleep disorders.